127 related articles for article (PubMed ID: 27774725)
1. Nanoscale Biodegradable Organic-Inorganic Hybrids for Efficient Cell Penetration and Drug Delivery.
Hörner S; Knauer S; Uth C; Jöst M; Schmidts V; Frauendorf H; Thiele CM; Avrutina O; Kolmar H
Angew Chem Int Ed Engl; 2016 Nov; 55(47):14842-14846. PubMed ID: 27774725
[TBL] [Abstract][Full Text] [Related]
2. Non-Covalent Loading of Anti-Cancer Doxorubicin by Modularizable Peptide Self-Assemblies for a Nanoscale Drug Carrier.
Tomizaki KY; Kishioka K; Kataoka S; Miyatani M; Ikeda T; Komada M; Imai T; Usui K
Molecules; 2017 Nov; 22(11):. PubMed ID: 29113134
[TBL] [Abstract][Full Text] [Related]
3. Cube-octameric silsesquioxane-mediated cargo peptide delivery into living cancer cells.
Hörner S; Fabritz S; Herce HD; Avrutina O; Dietz C; Stark RW; Cardoso MC; Kolmar H
Org Biomol Chem; 2013 Apr; 11(14):2258-65. PubMed ID: 23250285
[TBL] [Abstract][Full Text] [Related]
4. Novel cell-penetrating peptides based on α-aminoxy acids.
Ma Y; Yang D; Ma Y; Zhang YH
Chembiochem; 2012 Jan; 13(1):73-9. PubMed ID: 22162305
[TBL] [Abstract][Full Text] [Related]
5. Novel cleavable cell-penetrating peptide-drug conjugates: synthesis and characterization.
Lelle M; Frick SU; Steinbrink K; Peneva K
J Pept Sci; 2014 May; 20(5):323-33. PubMed ID: 24677287
[TBL] [Abstract][Full Text] [Related]
6. Identification of BP16 as a non-toxic cell-penetrating peptide with highly efficient drug delivery properties.
Soler M; González-Bártulos M; Soriano-Castell D; Ribas X; Costas M; Tebar F; Massaguer A; Feliu L; Planas M
Org Biomol Chem; 2014 Mar; 12(10):1652-63. PubMed ID: 24480922
[TBL] [Abstract][Full Text] [Related]
7. Protease-Responsive Prodrug with Aggregation-Induced Emission Probe for Controlled Drug Delivery and Drug Release Tracking in Living Cells.
Cheng Y; Huang F; Min X; Gao P; Zhang T; Li X; Liu B; Hong Y; Lou X; Xia F
Anal Chem; 2016 Sep; 88(17):8913-9. PubMed ID: 27503607
[TBL] [Abstract][Full Text] [Related]
8. Thermosensitive magnetic liposomes with doxorubicin cell-penetrating peptides conjugate for enhanced and targeted cancer therapy.
Lin W; Xie X; Yang Y; Fu X; Liu H; Yang Y; Deng J
Drug Deliv; 2016 Nov; 23(9):3436-3443. PubMed ID: 27193383
[TBL] [Abstract][Full Text] [Related]
9. Ligand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cells.
Zhong Y; Yang W; Sun H; Cheng R; Meng F; Deng C; Zhong Z
Biomacromolecules; 2013 Oct; 14(10):3723-30. PubMed ID: 23998942
[TBL] [Abstract][Full Text] [Related]
10. PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy.
Yang Y; Yang Y; Xie X; Cai X; Zhang H; Gong W; Wang Z; Mei X
Biomaterials; 2014 May; 35(14):4368-81. PubMed ID: 24565519
[TBL] [Abstract][Full Text] [Related]
11. Enantiomer-specific bioactivities of peptidomimetic analogues of mastoparan and mitoparan: characterization of inverso mastoparan as a highly efficient cell penetrating peptide.
Jones S; Howl J
Bioconjug Chem; 2012 Jan; 23(1):47-56. PubMed ID: 22148546
[TBL] [Abstract][Full Text] [Related]
12. Enhanced cellular uptake of albumin-based lyophilisomes when functionalized with cell-penetrating peptide TAT in HeLa cells.
van Bracht E; Versteegden LR; Stolle S; Verdurmen WP; Woestenenk R; Raavé R; Hafmans T; Oosterwijk E; Brock R; van Kuppevelt TH; Daamen WF
PLoS One; 2014; 9(11):e110813. PubMed ID: 25369131
[TBL] [Abstract][Full Text] [Related]
13. Precise tetrafunctional streptavidin bioconjugates towards multifaceted drug delivery systems.
Xu D; Heck AJ; Kuan SL; Weil T; Wegner SV
Chem Commun (Camb); 2020 Aug; 56(68):9858-9861. PubMed ID: 32717008
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides.
Gautam A; Sharma M; Vir P; Chaudhary K; Kapoor P; Kumar R; Nath SK; Raghava GP
Eur J Pharm Biopharm; 2015 Jan; 89():93-106. PubMed ID: 25459448
[TBL] [Abstract][Full Text] [Related]
15. Second generation, arginine-rich (R-X'-R)(4)-type cell-penetrating α-ω-α-peptides with constrained, chiral ω-amino acids (X') for enhanced cargo delivery into cells.
Patil KM; Naik RJ; Vij M; Yadav AK; Kumar VA; Ganguli M; Fernandes M
Bioorg Med Chem Lett; 2014 Sep; 24(17):4198-202. PubMed ID: 25096299
[TBL] [Abstract][Full Text] [Related]
16. Polyhedral oligomeric silsesquioxane-F68 hybrid vesicles for folate receptor targeted anti-cancer drug delivery.
Nair BP; Vaikkath D; Nair PD
Langmuir; 2014 Jan; 30(1):340-7. PubMed ID: 24354352
[TBL] [Abstract][Full Text] [Related]
17. Cellular uptake on N- and C-termini conjugated FITC of Rath cell penetrating peptides and its consequences for gene-expression profiling in U-937 human macrophages and HeLa cervical cancer cells.
Kuo JH; Lin CW
J Drug Target; 2013 Nov; 21(9):801-8. PubMed ID: 23937069
[TBL] [Abstract][Full Text] [Related]
18. Cell penetrating peptides from agglutinin protein of Abrus precatorius facilitate the uptake of Imatinib mesylate.
Behera B; Mukherjee D; Agarwal T; Das J; Ghosh SK; Maiti TK
Colloids Surf B Biointerfaces; 2016 Apr; 140():169-175. PubMed ID: 26752214
[TBL] [Abstract][Full Text] [Related]
19. Targeted delivery of doxorubicin to mitochondria.
Chamberlain GR; Tulumello DV; Kelley SO
ACS Chem Biol; 2013 Jul; 8(7):1389-95. PubMed ID: 23590228
[TBL] [Abstract][Full Text] [Related]
20. A lysosome-targeted drug delivery system based on sorbitol backbone towards efficient cancer therapy.
Maniganda S; Sankar V; Nair JB; Raghu KG; Maiti KK
Org Biomol Chem; 2014 Sep; 12(34):6564-9. PubMed ID: 25062087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
